Filing Flows › Sotera Health (SHC) › How it makes money
How Sotera Health (SHC) makes money
Sotera Health (SHC) made $325M of revenue in the third quarter 2026 (Q3 2026), +4% from a year earlier. Sterigenics brought in $209M (64%); Nelson Labs brought in $60.6M (19%); Nordion brought in $55.0M (17%). Of every dollar of revenue, 56¢ was left as gross profit, 26¢ was left as operating profit, 18¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Sterigenics | $209M | 64.4% | -1% | +9% |
| Nelson Labs | $60.6M | 18.6% | -0.2% | +9% |
| Nordion | $55.0M | 16.9% | +12% | -12% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $325M | 100.0% |
| Cost of revenue | $144M | 44.4% |
| Gross profit | $181M | 55.6% |
| Operating expenses | $97.1M | 29.9% |
| Operating profit | $83.7M | 25.8% |
| Income tax | $25.3M | 7.8% |
| Net earnings | $58.4M | 18.0% |
| Operating cash flow | $111M | 34.0% |
| Free cash flow | $57.7M | 17.8% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $325M | +4% |
| Q2 2026 | $321M | +9% |
| Q1 2026 | $280M | +10% |
| Q4 2025 | $303M | +5% |
| Q3 2025 | $311M | +9% |
| Q2 2025 | $294M | +6% |
| Q1 2025 | $255M | +3% |
From Sotera Health's 10-Q filed Nov 3, 2026 (on EDGAR).
Questions
How does Sotera Health make money?
Sotera Health (SHC) made $325M of revenue in the third quarter 2026 (Q3 2026), +4% from a year earlier. Sterigenics brought in $209M (64%); Nelson Labs brought in $60.6M (19%); Nordion brought in $55.0M (17%). Of every dollar of revenue, 56¢ was left as gross profit, 26¢ was left as operating profit, 18¢ was left as net earnings.
What is Sotera Health's biggest business?
Sterigenics: $209M in the third quarter 2026, 64% of revenue, +9% from a year earlier.
What is Sotera Health's profit margin?
Net earnings were $58.4M, 18.0% of revenue, in the third quarter 2026; the operating margin was 25.8%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.